You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Locally Advanced or Metastatic

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced or Metastatic Solid Tumors Trial in Beijing (MSC-IFNa, Nab paclitaxel, Cyclophosphamide)

Recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • MSC-IFNα
  • +3 more
  • Beijing, China
    Department of Biotherapeutic, Chinese PLA General Hospital
Jan 29, 2023

Quality of Life, Locally Advanced Pancreatic Carcinoma, Metastatic Pancreatic Cancer Trial (ARACOMPLEX®, )

Not yet recruiting
  • Quality of Life
  • +2 more
  • ARACOMPLEX®
  • placebo
  • (no location specified)
Nov 28, 2022

Protein Kinase Inhibitors, Other Protocol Specified Criteria, Lung Tumors Trial in Guangzhou (JYP0322)

Recruiting
  • Protein Kinase Inhibitors
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Nov 9, 2023

Locally Advanced/Metastatic Solid Tumors Trial in Newport Beach, San Diego, Canton (FL115)

Active, not recruiting
  • Locally Advanced/Metastatic Solid Tumors
  • Newport Beach, California
  • +2 more
Nov 10, 2023

Advanced/Metastatic Solid Tumors Trial in Frankston, Nedlands, Beijing (EMB07)

Not yet recruiting
  • Advanced/Metastatic Solid Tumors
  • Frankston, Victoria, Australia
  • +2 more
Nov 3, 2022

Renal Cell Carcinoma Trial (Pembrolizumab)

Completed
Has Results
  • Renal Cell Carcinoma
  • Pembrolizumab
  • (no location specified)
Aug 17, 2022

Locally Advanced/Metastatic Solid Tumors Trial (HY-0102)

Not yet recruiting
  • Locally Advanced/Metastatic Solid Tumors
  • (no location specified)
Jan 4, 2022

Umorestat Hydrogen Sulfate Capsule in Locally

Recruiting
  • Pharmacokinetics
  • +2 more
  • Genotyping
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-sen University
Apr 7, 2022

Advanced Solid Tumor Trial in Shanghai (HY-0102)

Not yet recruiting
  • Advanced Solid Tumor
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 19, 2023

Advanced Tumors, Lymphoma, Metastatic Tumors Trial in Changchun, Jinan (HLX301)

Recruiting
  • Advanced Tumors
  • +2 more
  • Changchun, Jilin, China
  • +1 more
Jul 12, 2022

Metastatic Hepatocellular Carcinoma Trial in Houston (Atezolizumab, Bevacizumab, ADI-PEG 20)

Not yet recruiting
  • Metastatic Hepatocellular Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 24, 2023

Patients' Whole Process Follow-up Management

Recruiting
  • Locally Advanced Non-Small Cell Lung Cancer
  • Metastatic NSCLC
  • Patients' whole process follow-up and management platform
  • Jinan, Shandong, China
    The First Affiliated Hospital of Shandong First Medical Universi
Sep 5, 2022

Locally Advanced/Metastatic Solid Tumors Trial in United States (BJ-001, Pembrolizumab)

Recruiting
  • Locally Advanced/Metastatic Solid Tumors
  • Saint Louis, Missouri
  • +4 more
Jun 5, 2022

Solid Tumor Trial (BB-1705)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
May 16, 2022

Locally Advanced/Metastatic Solid Tumors Trial in Shanghai (PE0116)

Active, not recruiting
  • Locally Advanced/Metastatic Solid Tumors
  • Shanghai, China
    复旦大学附属中山医院
Mar 23, 2023

Recurrent Vulvar Cancer, Persistent Vulvar Cancer, Metastatic Vulva Cancer Trial (Pembrolizumab, Lenvatinib)

Not yet recruiting
  • Recurrent Vulvar Cancer
  • +3 more
  • (no location specified)
Jun 12, 2023

Ovarian Cancer, Melanoma, Triple Negative Breast Cancer Trial (NM1F Injection, Pembrolizumab injection)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • NM1F Injection
  • Pembrolizumab injection
  • (no location specified)
Feb 23, 2023

Solid Tumors Trial (IBR854 Cell Injection)

Not yet recruiting
  • Solid Tumors
  • IBR854 Cell Injection
  • (no location specified)
Aug 14, 2023

Locally Advanced Angiosarcoma, Metastatic Angiosarcoma, Recurrent Angiosarcoma Trial in Houston (Quality-of-Life Assessment,

Recruiting
  • Locally Advanced Angiosarcoma
  • +2 more
  • Quality-of-Life Assessment
  • Sintilimab
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Locally Advanced Solid Tumors, Recurrent Solid Tumors, Metastatic Solid Tumors Trial (RO7566802, Atezolizumab)

Not yet recruiting
  • Locally Advanced Solid Tumors
  • +2 more
  • (no location specified)
Sep 4, 2023

Differentiated Thyroid Cancer Trial in Shanghai (surufatinib)

Recruiting
  • Differentiated Thyroid Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 9, 2023

Metastatic Pancreatic Cancer Trial (FOLFIRINOX treatment)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • FOLFIRINOX treatment
  • (no location specified)
Aug 9, 2023

Locally Advanced Adrenal Cortical Carcinoma, Metastatic Adrenal Cortical Carcinoma, Stage III Adrenal Cortical Carcinoma AJCC v8

Not yet recruiting
  • Locally Advanced Adrenal Cortical Carcinoma
  • +4 more
  • Atezolizumab
  • +5 more
  • Atlanta, Georgia
  • +1 more
Aug 17, 2023

Chordoma Trial in Essen, Heidelberg, Ulm (Palbociclib)

Recruiting
  • Chordoma
  • Essen, Germany
  • +2 more
Dec 6, 2021

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Ocala, Florida
    Ocala Oncology Center PL DBA Florida Cancer Affiliates
Jul 19, 2023